Target intelligence / Profile preview

RNA, U6 small nuclear 1053, pseudogene (RNU6-1053P)

Target: RNU6-1053P
Molecular classification: Pseudogene, Small nuclear RNA (snRNA) pseudogene

Overview

RNU6-1053P is a processed pseudogene of the U6 small nuclear RNA gene, found on human chromosome 4. Like other snRNA pseudogenes, it arises from the retrotransposition of an RNA intermediate, often via LINE-1 (L1) machinery, and does not encode a functional product. U6 pseudogenes, including RNU6-1053P, can serve as useful markers in genomics to assess the dynamics of retrotransposition activity in the genome, but they do not have canonical gene function. There is no current evidence that RNU6-1053P is expressed or has clinical significance. Key Points: - RNU6-1053P is not a protein-coding gene, not a functional snRNA, and not a therapeutic target. - It is a genomic marker for studies of retrotransposition, with no known role in disease or therapy. - No known aliases beyond those given, and no implications for drugs or biomarkers in patient care.

Other names: RNU6-1053PRNA, U6 small nuclear 1053, pseudogene

Mechanism of action

None (not a drug target)

Biological functions

Not known to have a direct biological function; pseudogenes generally do not encode active molecules, although some may participate in regulatory roles or genome evolution. The parental functional U6 snRNA is involved in the spliceosome and pre-mRNA splicing, but the pseudogene itself lacks this activity

Disease associations

None established for this pseudogene; although some pseudogenes play regulatory roles in disease, there is no evidence for disease association for RNU6-1053P specifically

Beyond the preview

Go deeper on RNA, U6 small nuclear 1053, pseudogene (RNU6-1053P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1053, pseudogene (RNU6-1053P).

Explore the full profile